There were similar expression levels of complement inhibitory receptors between COVID-19 recovered patients and HCs consistent with the initial increase in CD55 returning to normal levels post-recovery from COVID-19 (Supplementary Figures 2A–D). The gene discussed is CD55; the disease is COVID-19.